Trase Raises $107M Seed

Trase, a McLean, Virginia-based developer of an AI operating system for highly regulated industries, has raised $107 million in seed funding. This latest injection of capital brings the company's total funding to $117.5 million, supporting its mission to provide infrastructure for AI agents in sectors such as health care and defense.

Investors

The funding round was led by Arch Venture Partners, with participation from Red Cell Partners.

Trase Use of Funds

Trase plans to use the new capital to scale its operations and continue the development of its core operating system, Trase Origin. The company also intends to pursue strategic tuck-in acquisitions that align with its focus on agentic AI and help accelerate customer growth.

About Trase

Founded by CEO Grant Verstandig, Trase provides an operating system and infrastructure layer designed for AI agents operating in highly regulated fields. The company acts as the connective tissue that integrates disparate data sources, foundation models, and subject matter expertise to solve complex operational challenges.

Funding Details

Company Website: https://trase.ai

Company: Trase
Raised: $107M
Round: Seed
Funding Date: June 24, 2026
Lead Investor: Arch Venture Partners
Additional Investors: Red Cell Partners
Software Category: Artificial Intelligence
Source: https://www.axios.com/pro/health-tech-deals/2026/06/24/trase-107-million-health-care-defense-ai